Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

A How-To Guide for Integrating OUD Treatment into Your Practice (APP Prescribers Additional X-Waiver 16 Hours Training)

October 14, 2021
3:00 pm–5:00 pm ET

This training is part 4 of 8 for the training series that will provide APPs the additional 16 hours to meet the requirements to obtain a Medication for Opioid Use Disorder (MOUD) X-Waiver Certificate that will allow them to prescribe to more than 30 patients.

Register now

Virtual meeting

Via Zoom

Description

In accordance with 2021 changes in practice guidelines for administering buprenorphine for the treatment of opioid use disorder, Advanced Practice Providers (APPs) are required to apply to the Drug Enforcement Agency for a waiver to prescribe buprenorphine. In order to treat more than 30 patients, APPs must complete 24 hours of specialized training —an eight-hour Medication for Opioid Use Disorder (MOUD) X-Waiver training course plus an additional 16 hours of training. Until now, the additional 16 hours has primarily been available through online, pre-recorded modules.

Boston Medical Center’s OBAT TTA is proud to announce a no-cost, live training series that will provide APPs the additional 16 hours to meet these requirements. This training was developed by and for APPs.

The 4th session in this series is titled "A How-To Guide for Integrating OUD Treatment into Your Practice." 

Intended audience

Nurse Practitioners, Certified Nurse Midwives (CNM), Clinical Nurse Specialists (CNS), Certified Registered Nurse Anesthetists (CRNA), and Physician Assistants

Speakers

Justin Alves, RN, MSN, ACRN, CARN, CNE

Justin is a Clinical Nurse Educator for Boston Medical Center's OBAT TTA team, with specific expertise in infectious disease and their co-occurrence with substance use disorders, community outreach, and harm reduction. He serves as an expert on OBAT TTA's SUD Care Continuum ECHO team and sits on the item writing committee for the Addictions Nursing Certification Board. Justin has dedicated his career to caring for patients living with HIV/AIDS and suffering from substance use disorders across the continuum of care. He is an AIDS Certified Registered Nurse, a Certified Addictions Registered Nurse, and a member of the Gamma Epsilon Chapter of Sigma Theta Tau. Justin received his BSN from Northeastern University in 2013 and received his MSN, with a focus in nursing education, from the University of Massachusetts-Dartmouth in 2020.

Kristin Wason, MSN, NP-C, CARN

Kristin is a Nurse Practitioner at Boston Medical Center and Assistant Professor of Medicine at Boston University School of Medicine. Kristin has been working in addiction medicine since 2009 — initially practicing as a Registered Nurse within BMC's multidisciplinary OBAT clinic, managing a large caseload of patients with substance addiction, and now as a Primary Care Provider with a full DATA2000 X-waiver. In addition to her clinical practice, Kristin advises and supports community health centers on integration of best practices for treating substance use disorders into institutions across Massachusetts and nationwide. Kristin earned her MSN, Adult-Gerontology Nurse Practitioner, degree from Salem State University. She is board certified in addictions nursing through the Addictions Nursing Certification Board.

Objectives

Participants will be able to:

Sponsored by

Bureau of Substance Addiction Services (DPH/BSAS), Providers Clinical Support System (PCSS), and Boston Medical Center Office Based Addiction Treatment and Technical Assistance (BMC OBAT TTA). 

American Academy of Addiction Psychiatry (AAAP) is the DATA 2000 sponsor for this waiver training.

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

For more information, visit www.pcssNOW.org

Accreditation information

ACCME Accreditation Statement

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Boston University School of Medicine designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Register now

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.


© 2024 Boston Medical Center. All rights reserved. Site by Root802.